BeyondSpring Inc.
BYSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677940
No open-market purchases or sales by BeyondSpring Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $10.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in BeyondSpring Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q1 2025
- Shares held
- 6.00M
- +744.2K (+14.2%) vs. Q1 2025
- Total value
- $14.1M
- +$6.60M (+87.9%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 3
- 5 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BYSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $10.6M |
| Q1 2026 | 20 | $9.81M |
| Q4 2025 | 23 | $9.76M |
| Q3 2025 | 18 | $10.7M |
| Q2 2025 | 16 | $14.1M |
| Q1 2025 | 17 | $7.55M |
| Q4 2024 | 16 | $8.59M |
| Q3 2024 | 16 | $12.7M |
| Q2 2024 | 18 | $13.9M |
| Q1 2024 | 22 | $21.0M |
| Q4 2023 | 21 | $4.91M |
| Q3 2023 | 26 | $4.52M |
| Q2 2023 | 26 | $6.73M |
| Q1 2023 | 27 | $6.65M |
| Q4 2022 | 29 | $11.3M |
| Q3 2022 | 33 | $6.99M |
| Q2 2022 | 46 | $12.8M |
| Q1 2022 | 67 | $26.4M |
| Q4 2021 | 67 | $35.1M |
| Q3 2021 | 76 | $153.3M |
| Q2 2021 | 59 | $77.9M |
| Q1 2021 | 64 | $78.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding BeyondSpring Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 9 | $21 | 0.00% | +9 | New |
| SBI Securities Co., Ltd. | 87 | $204 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 143 | $336 | 0.00% | −457−76.2% | Reduced |
| Tower Research Capital LLC (TRC) | 253 | $595 | 0.00% | +253 | New |
| Steward Partners Investment Advisory, LLC | 1,080 | $2.54K | 0.00% | 00.0% | Unchanged |
| Trifecta Capital Advisors, LLC | 1,500 | $3.52K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,875 | $6.73K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,951 | $16.3K | 0.00% | −33,930−83.0% | Reduced |
| Bank of America Corp | 7,771 | $18.3K | 0.00% | −79−1.0% | Reduced |
| Morgan Stanley | 8,210 | $19.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,600 | $27.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,309 | $38.3K | 0.00% | −396−2.4% | Reduced |
| Geode Capital Management, LLC | 256,212 | $602.5K | 0.00% | +231,844+951.4% | Added |
| Vanguard Group Inc | 523,699 | $1.23M | 0.00% | +523,699 | New |
| BlackRock, Inc. | 635,085 | $1.49M | 0.00% | +415,172+188.8% | Added |
| Decheng Capital LLC | 4,531,481 | $10.6M | 2.69% | −351,170−7.2% | Reduced |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,031−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,679−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Tanaka Capital Management Inc | – | – | – | – | Not filed |